Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Neuropsychopharmacology

• Publication date

  2012-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1017/S1461145711001003PMID 21733229PMCID PMC3204186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

  2011influential reference
• Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole

  2010cited by this paper
• Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder.

  2010cited by this paper
• Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.

  2010cited by this paper
• Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

  2010influential reference
• Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.

  2010cited by this paper
• Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.

  2010influential reference
• Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid

  2010cited by this paper
• The mood stabilizer lamotrigine produces antidepressant behavioral effects in rats: role of brain-derived neurotrophic factor

  2010cited by this paper
• Imaging Elevated Brain Arachidonic Acid Signaling in Unanesthetized Serotonin Transporter (5-HTT)-Deficient Mice

  2009influential reference
• Bipolar disorder and mechanisms of action of mood stabilizers.

  2009influential reference
• Chronic Administration of Mood Stabilizers Upregulates BDNF and Bcl-2 Expression Levels in Rat Frontal Cortex

  2009cited by this paper
• Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells.

  2009cited by this paper
• Chronic Administration of Lamotrigine Downregulates COX-2 mRNA and Protein in Rat Frontal Cortex

  2008influential reference
• Chronic Administration of Valproic Acid Reduces Brain NMDA Signaling via Arachidonic Acid in Unanesthetized Rats

  2008cited by this paper
• Chronic Carbamazepine Administration Attenuates Dopamine D2-like Receptor-Initiated Signaling via Arachidonic Acid in Rat Brain

  2008influential reference
• Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings.

  2007cited by this paper
• Retracted: Chronic NMDA administration to rats up‐regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein‐2

  2007influential reference
• Flurbiprofen, A Cyclooxygenase Inhibitor, Reduces the Brain Arachidonic Acid Signal in Response to the Cholinergic Muscarinic Agonist, Arecoline, in Awake Rats

  2007influential reference
• Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release.

  2007cited by this paper
• RETRACTED: Chronic administration of carbamazepine down-regulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex.

  2007cited by this paper
• Chronic lithium administration attenuates up‐regulated brain arachidonic acid metabolism in a rat model of neuroinflammation

  2007influential reference
• Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.

  2007cited by this paper
• Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA.

  2007influential reference
• Increased levels of glutamate in brains from patients with mood disorders.

  2007cited by this paper
• Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder

  2007influential reference
• Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain.

  2007influential reference
• Increased Anterior Cingulate/Medial Prefrontal Cortical Glutamate and Creatine in Bipolar Depression

  2007cited by this paper
• Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder.

  2006influential reference
• Chronic Lithium Chloride Administration Attenuates Brain NMDA Receptor-Initiated Signaling via Arachidonic Acid in Unanesthetized Rats

  2006influential reference
• Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.

  2006cited by this paper
• Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.

  2006cited by this paper
• Resting and arecoline‐stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase‐2 knockout mouse

  2006influential reference
• An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.

  2005cited by this paper
• Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism

  2005cited by this paper
• Transcription of the NR1 Subunit of the N-Methyl-d-aspartate Receptor Is Down-regulated by Excitotoxic Stimulation and Cerebral Ischemia *

  2005cited by this paper
• A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

  2005cited by this paper
• Treatment options for bipolar depression.

  2005cited by this paper
• α‐Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid

  2005influential reference
• Topiramate does not Alter the Kinetics of Arachidonic or Docosahexaenoic Acid in Brain Phospholipids of the Unanesthetized Rat

  2005cited by this paper
• Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks.

  2005cited by this paper
• Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats.

  2004influential reference
• Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain.

  2004cited by this paper
• Synthesis and function of hepatic very-low-density lipoprotein.

  2004cited by this paper
• The effect of Vigabatrin, Lamotrigine and Gabapentin on the fertility, weights, sex hormones and biochemical profiles of male rats.

  2004influential reference
• Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder

  2004cited by this paper
• The current understanding of lamotrigine as a mood stabilizer.

  2004cited by this paper
• NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder.

  2004cited by this paper
• Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium

  2004cited by this paper
• Topiramate and Lamotrigine Pharmacokinetics during Repetitive Monotherapy and Combination Therapy in Epilepsy Patients

  2003influential reference
• Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.

  2003cited by this paper
• Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex

  2003cited by this paper
• Regulation of Cellular Plasticity Cascades in the Pathophysiology and Treatment of Mood Disorders

  2003cited by this paper
• Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders

  2003cited by this paper
• In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism.

  2003cited by this paper
• In vivo activation of N‐methyl‐d‐aspartate receptors in the rat hippocampus increases prostaglandin E2 extracellular levels and triggers lipid peroxidation through cyclooxygenase‐mediated mechanisms

  2002cited by this paper
• Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity

  2002influential reference
• Cyclooxygenase-2 is a neuronal target gene of NF-κB

  2002cited by this paper
• Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.

  2002cited by this paper
• Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?

  2002influential reference
• Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels.

  2001influential reference
• In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling

  2001cited by this paper
• Glutathione-S-transferase family of enzymes.

  2001cited by this paper
• Glutathione S-Transferase Polymorphisms and Their Biological Consequences

  2000influential reference
• Perfusion of the hypothalamic paraventricular nucleus with N-methyl-D-aspartate produces thromboxane A2 and centrally activates adrenomedullary outflow in rats.

  2000cited by this paper
• The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro.

  2000cited by this paper
• Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

  2000influential reference
• Computer-Assisted Research Design and Analysis

  2000cited by this paper
• 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain.

  1999cited by this paper
• Group-specific assays that distinguish between the four major types of mammalian phospholipase A2.

  1999cited by this paper
• PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat.

  1998cited by this paper
• An region upstream of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells.

  1998cited by this paper
• Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A

  1998cited by this paper
• Cellular and Molecular Actions of Lamotrigine: Possible Mechanisms of Efficacy in Bipolar Disorder

  1998influential reference
• Lamotrigine Inhibits Extracellular Glutamate Accumulation during Transient Global Cerebral Ischemia in Rabbits

  1997influential reference
• No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat.

  1997cited by this paper
• Cyclic AMP-dependent Protein Kinase and Protein Kinase C Phosphorylate N-Methyl-d-aspartate Receptors at Different Sites*

  1997cited by this paper
• Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons

  1996influential reference
• Lithium decreases turnover of arachidonate in several brain phospholipids.

  1996cited by this paper
• Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family

  1995cited by this paper
• Developmental and regional expression pattern of a novel NMDA receptor- like subunit (NMDAR-L) in the rodent brain

  1995cited by this paper
• Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents.

  1994cited by this paper
• Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex.

  1993influential reference
• A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis.

  1992cited by this paper
• A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP.

  1991influential reference
• Intravenous injection of [1‐14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats

  1989influential reference
• NMDA receptors activate the arachidonic acid cascade system in striatal neurons

  1988cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• AChE-stained horizontal sections of the rat brain in stereotaxic coordinates.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Neuropharmacology

  1958cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957influential reference

• Antidépresseurs : aspects pharmacologiques

  2026cites this paper
• LINKING BRAIN ENTROPY TO MOLECULAR AND CELLULAR ARCHITECTURE IN PSYCHOSIS

  2025cites this paper
• Linking brain entropy to molecular and cellular architecture in psychosis

  2025cites this paper
• Modeling Lamotrigine-Induced Reprotoxicity in Porcine Endometrial Organoids: Integrated Multi-platform Profiling.

  2025cites this paper
• Lamotrigine as a preventive agent against recurrent catatonia in adult-onset Niemann-Pick Type-C disease: a case report

  2024cites this paper
• Pharmaco-psychiatry and gut microbiome: a systematic review of effects of psychotropic drugs for bipolar disorder

  2024cites this paper
• Attenuation of severe ketamine-induced neuropsychiatric side effects by lamotrigine in a patient with treatment resistant bipolar depression: a case report

  2023cites this paper
• Novel pharmacotherapy targeting the positive symptoms of schizophrenia

  2023cites this paper
• Zingerone neuroprotective effects in a rat model of manic-like behavior induced by ketamine

  2023cites this paper
• Untangling Psychology from Biology in the Treatment of Psychiatric Disorders

  2023cites this paper
• Individuals with Bipolar Disorder Have a Higher Level of Homocysteine Than Major Depressive Disorder: A Retrospective Chart Review and Observational Study

  2022cites this paper
• Ketamine and Lamotrigine Combination in Psychopharmacology: Systematic Review

  2022cites this paper
• Combined cell grafting and VPA administration facilitates neural repair through axonal regeneration and synaptogenesis in traumatic brain injury

  2022cites this paper
• Dynamics of Cyclooxygenase-1 Positive Microglia/Macrophage in the Retina of Pathological Model Mice as a Biomarker of the Retinal Inflammatory Diseases

  2021cites this paper
• Antiepileptic drugs

  2020cites this paper
• Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson’s

  2019cites this paper
• Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence

  2018cites this paper
• A Simple and Highly Sensitive Quantitation of Eicosanoids in Biological Samples Using Nano-flow Liquid Chromatography/ Mass Spectrometry

  2018cites this paper
• 1 Bivalent Cations in Bipolar Disorders

  2017cites this paper
• The effect of lamotrigine on learning in mice using the passive avoidance model.

  2017cites this paper
• Antidépresseurs : aspects pharmacologiques

  2016cites this paper
• Evaluation of the efficacy of adjunctive lamotrigine in the treatment of epilepsy and depression with Meta-analysis

  2016cites this paper
• Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test.

  2016cites this paper
• Glutamatergic Agents as Add-On Medication for the Treatment of Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis.

  2016cites this paper
• The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder

  2015cites this paper
• Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries.

  2015cites this paper
• Bipolar disorder and antibodies against the N-methyl-d-aspartate receptor: A gate to the involvement of autoimmunity in the pathophysiology of bipolar illness.

  2015cites this paper
• Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer

  2015cites this paper
• Lithium an emerging contaminant: bioavailability, effects on protein expression, and homeostasis disruption in short-term exposure of rainbow trout.

  2015cites this paper
• The role of NMDA receptors in the pathophysiology and treatment of mood disorders.

  2014cites this paper
• Lamotrigine in an experimental animal model of inflammatory pain.

  2014cites this paper
• Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.

  2014cites this paper
• Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

  2012influential citation
• Bivalent Cations in Bipolar Disorders

  2012cites this paper
• Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial

  2012cites this paper
• Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.

  2011cites this paper
• Untangling Psychology from Biology in the Treatment of 1 Psychiatric Disorders 2

  year unknowncites this paper